Skip Navigation

U.S. Department of Health and Human Services • National Institutes of Health

Advanced Search

NIAID > Labs & Scientific Resources > Technology Development

Technology Development

Model Agreements and Definitions

Recent Opportunities

Success Stories

Recent Happenings

Technology Transfer Fellowship Program

Skip Website Tools

Website Tools

Skip Stay Connected

Stay Connected

Stay connected on Facebook

Stay connected on Twitter

Stay connected on flickr

Stay connected on YouTube

Stay connected on LinkedIn

Social media privacy policy and disclaimers.

photo of mouse nerve cells

Read how NIAID scientists are progressing toward a faster, more practical way to screen people and animals for prion diseases.

External Resources

View a list of links for more information about technology development.

noJavaScriptImage

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on. Read more information on enabling JavaScript.

Technology Development

Skip Content Marketing

Share this:

Recent Licensing and Collaboration Opportunities

Click the text below to find or hide additional information.

Antimicrobial (Drug) Resistance

PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus aureus

Biodefense

Protease Deficient Bacillus anthracis With Improved Recombinant Protein Yield Capabilities

Axenically-Produced Coxiella burnetii and Methods for Producing Axenic Coxiella burnetii

Cancer

Therapeutic Approach for Autoimmune Diseases, Inflammatory Diseases and Cancers by Blocking CIKS-TRAF6 Interactions

Novel Method of Treating Cancer Using Ixolaris

Hepatitis

Infectious Hepatitis E Virus Genotype 3 Recombinants—Prospective Vaccine Candidates and Vector System

A Novel System for Producing Infectious Hepatitis C Virus (HCV) Virions and Development of a Novel Reporter System for Studying HCV Entry

Herpes/Herpes Viruses

Prevention and Treatment of Herpes Virus Infection by Inhibition of the JMJD2 Family of Histone Demethylases

Use of Mono-Amine Oxidase Inhibitors To Prevent Herpes Virus Infections and Reactivation From Latency

HIV/AIDS

Improved Standard for Immune System Recovery Assay

HIV-1 Neutralization by sCD4-17b a Novel Chimeric Bifunctional Protein for Prevention and Treatment of HIV

Novel System for HIV-1 Vaccine Development

Mouse Model of Individual Unresponsive to Interferon

Immune and Autoimmune Disorders

Improved Standard for Immune System Recovery Assay

Mouse Model of Individual Unresponsive to Interferon

Therapeutic Approach for Autoimmune Diseases, Inflammatory Diseases and Cancers by Blocking CIKS-TRAF6 Interactions

Neglected Tropical Diseases

see also Parasitic/Vector-Borne Diseases

Parasitic/Vector-Borne Diseases

Transmission-Blocking Malaria Vaccine

Antimalarial Inhibitors that Target the Plasmodial Surface Anion Channel (PSAC) Protein and Development of the PSAC Protein as Vaccine Targets

Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)

Rapid Molecular Assays for Specific Detection and Quantitation of Loa loa Microfilaremia

Diagnostic Assays and Methods of Use for Detection of Filarial Infection

Multivalent Vaccines for Rabies Virus and Filoviruses

Method To Create Vaccines for the Prevention of Flavivirus Infections by Targeting Micro-RNA

Compositions and Methods for Controlling Neurotropic Viral Pathogenesis by Micro-RNA Targeting

Compounds That Treat Malaria and Prevent Malaria Transmission

A Novel Treatment for Malarial Infections

Chondroitin Sulphate A Binding Domains: Potential Vaccine for Malaria

Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses

Novel Antigen for Use as Vaccine Against Nematode Infection

Respiratory Diseases

Salen-Manganese Compounds for Therapy of Viral Infections

Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine

Treatment of Tuberculosis—Adjuvant Therapies To Increase the Efficiency of Antibiotic Treatments

Poultry Influenza Vaccine

Sexually Transmitted Diseases

Use of Mono-Amine Oxidase Inhibitors To Prevent Herpes Virus Infections and Reactivation From Latency

Prevention and Treatment of Herpes Virus Infection by Inhibition of the JMJD2 Family of Histone Demethylases

Research Tools, Animal Models, and Assays

Rapid Molecular Assays for Specific Detection and Quantitation of Loa loa Microfilaremia

Diagnostic Assays and Methods of Use for Detection of Filarial Infection

Improved Standard for Immune System Recovery Assay

Method of Producing Immortalized Primary Human Keratinocytes for HPV Investigation, Testing of Therapeutics, and Skin Graft Generation

Mouse Model of Individual Unresponsive to Interferon

Mouse IL-12p40 Expressing Cell line

Microwave-Assisted Freeze Substitution of Biological and Biomedical Samples

Sound Attenuation Canopy for Reducing Noise Transmitted Through Suspended Ceilings

Vaccines

Self-Assembled Ferritin Nanoparticles Expressing Hemagglutinin as an Influenza Vaccine

Multivalent Vaccines for Rabies Virus and Filoviruses

Aerosolized Vaccines

Methods To Increase Stability of Recombinant Vaccinia-Vectored Vaccines and Increase Expression of a Foreign Gene Inserted in Such Vaccines

Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses

Novel Antigen for Use as Vaccine Against Nematode Infection

Novel System for HIV-1 Vaccine Development

Last Updated November 02, 2012

Last Reviewed January 18, 2011

Home | Contact Us | Help | Site Map | Accessibility | Privacy Policy | Disclaimer | Website Links & Policies | FOIA | NIAID Employee Emergency Information

U.S. Department of Health and Human Services Text

National Institutes of Health Text